Bifidobacteria-Host Interactions - An Update on Colonisation Factors

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Grimm, Verena ^a   Westermann, Christina ^a   Riedel, Christian U ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL PROTEIN; BILE SALT; CARBOHYDRATE; EPS PROTEIN; PREBIOTIC AGENT; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; BACTERIAL COLONIZATION; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL STRUCTURES; BIFIDOBACTERIACEAE; BILE; CELL ADHESION; GASTROINTESTINAL TRACT; GASTROINTESTINAL TRANSIT; GENE SEQUENCE; HEALTH; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; NONHUMAN; PROTEOMICS; REVIEW; SMALL INTESTINE; STOMACH; BIFIDOBACTERIUM; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; MICROFLORA;

BACTERIA (MICROORGANISMS);

BIFIDOBACTERIUM; GASTROINTESTINAL TRACT; HOST-PATHOGEN INTERACTIONS; HUMANS; MICROBIOTA; PROBIOTICS;

EID: 84930788842     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/960826     Document Type: Review

References (135)

1. M. Wilson, "The indogenous microbiota of the gastrointestinal tract, " in Bacteriology of Humans: An Ecological Perspective, M. Wi, Ed., pp. 266-326, Blackwell Publishing, Oxford, UK, 2008.
2. J. L. Round and S. K. Mazmanian, "The gutmicrobiota shapes intestinal immune responses during health and disease, " Nature Reviews Immunology, vol. 9, no. 5, pp. 313-323, 2009.
3. F. Sommer and F. Bäckhed, "Thegut microbiota-masters of host development and physiology, "Nature Reviews Microbiology, vol. 11, pp. 227-238, 2013.
4. S. Matamoros, C. Gras-Leguen, F. Le Vacon, G. Potel, and M.- F. de La Cochetiere, "Development of intestinal microbiota in infants and its impact on health, " Trends in Microbiology, vol. 21, no. 4, pp. 167-173, 2013.
5. S. Arboleya, P. Ruas-Madiedo, A. Margolles et al., "Characterization and in vitro properties of potentially probiotic Bifidobacteriumstrains isolated from breast-milk, " International Journal of Food Microbiology, vol. 149, no. 1, pp. 28-36, 2011.
6. L. Fernández, S. Langa, V. Martín et al., "The human milk microbiota: origin and potential roles in health and disease, " Pharmacological Research, vol. 69, pp. 1-10, 2013.
7. V. Martín, A. Maldonado-Barragán, L. Moles et al., "Sharing of bacterial strains between breast milk and infant feces, " Journal of Human Lactation, vol. 28, pp. 36-44, 2012.
8. K. Kurokawa, T. Itoh, T. Kuwahara et al., "Comparativemetagenomics revealed commonly enriched gene sets in human gut microbiomes, " DNA Research, vol. 14, no. 4, pp. 169-181, 2007.
9. T. Yatsunenko, F. E. Rey, M. J. Manary et al., "Human gut microbiome viewed across age and geography, " Nature, vol. 486, no. 7402, pp. 222-227, 2012.
10. F. Turroni, C. Peano, D. A. Pass et al., "Diversity of bifidobacteria within the infant gut microbiota, " PLoSONE, vol. 7, no. 5, Article ID e36957, 2012.
11. L. C. Roger, A. Costabile, D. T. Holland , L. Hoyles, and A. L. McCartney, "Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life, " Microbiology, vol. 156, no. 11, pp. 3329-3341, 2010.
12. C. U. Riedel, A. Schwiertz, and M. Egert, "The stomach and small and large intestinal microbiomes, " in The Human Microbiota and Microbiome, J. R. Marchesi, Ed., CABI, 2014.
13. J.-H. Lee and D. J. OSullivan, "Genomic insights into bifidobacteria, " Microbiology and Molecular Biology Reviews, vol. 74, no. 3, pp. 378-416, 2010.
14. M.-M. Grönlund, O.-P. Lehtonen, E. Eerola, and P. Kero, "Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery, " Journal of Pediatric Gastroenterology and Nutrition, vol. 28, no. 1, pp. 19-25, 1999.
15. J. Penders, C. Thijs, C. Vink et al., "Factors influencing the composition of the intestinal microbiota in early infancy, " Pediatrics, vol. 118, no. 2, pp. 511-521, 2006.
16. G. Biasucci, M. Rubini, S. Riboni, L. Morelli, E. Bessi, and C. Retetangos, "Mode of delivery affects the bacterial community in the newborn gut, " Early Human Development, vol. 86, supplement 1, pp. S13-S15, 2010.
17. E. Bezirtzoglou, A. Tsiotsias, and G. W. Welling, "Microbiota profile in feces of breast- and formula-fed newborns by using fluorescence in situ hybridization (FISH), " Anaerobe, vol. 17, no. 6, pp. 478-482, 2011.
18. M. J. Hopkins, R. Sharp, and G. T. Macfarlane, "Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles, " Gut, vol. 48, no. 2, pp. 198-205, 2001.
19. M. J. Claesson, S. Cusack, O. OSullivan et al., "Composition, variability, and temporal stability of the intestinalmicrobiota of the elderly, " Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 1, pp. 4586-4591, 2011.
20. L. Dethlefsen and D. A. Relman, "Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation, " Proceedings of the National Academy of Sciences of the United States of America, vol. 108, supplement, no. 1, pp. 4554-4561, 2011.
21. A. R. Manges, A. Labbe, V. G. Loo et al., "Comparative metagenomic study of alterations to the intestinal microbiota and risk of nosocomial clostridum difficile-associated disease, " Journal of Infectious Diseases, vol. 202, no. 12, pp. 1877-1884, 2010.
22. C. Vincent, D. A. Stephens, V. G. Loo et al., "Reductions in intestinal Clostridiales precede the development of nosocomial Clostridium difficile infection, " Microbiome, vol. 1, article 18, 2013.
23. A. P. M. Kerckhoffs, M. Samsom, M. E. van der Rest et al., "Lower Bifidobacteria counts in both duodenal mucosaassociated and fecal microbiota in irritable bowel syndrome patients, " World Journal of Gastroenterology, vol. 15, no. 23, pp. 2887-2892, 2009.
24. I. B. Jeffery, P. W. OToole, L. Öhman et al., "An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota, " Gut, vol. 61, no. 7, pp. 997-1006, 2012.
25. M. Rajilić-Stojanović, E. Biagi, H. G. H. J. Heilig et al., "Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome, " Gastroenterology, vol. 141, no. 5, pp. 1792-1801, 2011.
26. B. P. Willing, J. Dicksved, J. Halfvarson et al., "A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes, " Gastroenterology, vol. 139, no. 6, pp. 1844. e1-1854. e1, 2010.
27. P. Lepage, R. Hösler, M. E. Spehlmann et al., "Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis, " Gastroenterology, vol. 141, no. 1, pp. 227-236, 2011.
28. A. Schwiertz, M. Jacobi, J.-S. Frick, M. Richter, K. Rusch, and H. Köhler, "Microbiota in pediatric inflammatory bowel disease, " Journal of Pediatrics, vol. 157, no. 2, pp. 240.e1-244.e1, 2010.
29. D. N. Frank, A. L. St. Amand , R. A. Feldman, E. C. Boedeker, N. Harpaz, and N. R. Pace, "Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases, " Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 34, pp. 13780-13785, 2007.
30. J. Penders, C. Thijs, P. A. Van Den Brand t et al., "Gut microbiota composition and development of atopic manifestations in infancy: the KOALA birth cohort study, " Gut, vol. 56, no. 5, pp. 661-667, 2007.
31. M. Kalliomäki, P. Kirjavainen, E. Eerola, P. Kero, S. Salminen, and E. Isolauri, "Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing, " Journal of Allergy and Clinical Immunology, vol. 107, no. 1, pp. 129-134, 2001.
32. B. Björkstén, E. Sepp, K. Julge, T. Voor, and M. Mikelsaar, "Allergy development and the intestinal microflora during the first year of life, " Journal of Allergy and Clinical Immunology, vol. 108, no. 4, pp. 516-520, 2001.
33. M. de Angelis, M. Piccolo, L. Vannini et al., "Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified, " PLoS ONE, vol. 8, Article ID e76993, 2013.
34. J. B. Adams, L. J. Johansen, L. D. Powell, D. Quig, and R. A. Rubin, "Gastrointestinal flora and gastrointestinal status in children with autism-comparisons to typical children and correlation with autism severity, " BMC Gastroenterology, vol. 11, article 22, 2011.
35. H. M. R. T. Parracho, M. O. Bingham, G. R. Gibson, and A. L. McCartney, "Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children, " Journal of Medical Microbiology, vol. 54, no. 10, pp. 987-991, 2005.
36. E. G. Zoetendal, A. D. L. Akkermans, and W. M. De Vos, "Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria, " Applied and Environmental Microbiology, vol. 64, no. 10, pp. 3854-3859, 1998.
37. J. J. Faith, J. L. Guruge, M. Charbonneau et al., "The long-term stability of thehumangutmicrobiota, " Science, vol. 341, no. 6141, Article ID 1237439, 2013.
38. I. Sekirov, S. L. Russell, L. Caetano, M. Antunes, and B. B. Finlay, "Gut microbiota in health and disease, " Physiological Reviews, vol. 90, no. 3, pp. 859-904, 2010.
39. K. S. B. Bergstrom, V. Kissoon-Singh, D. L. Gibson et al., "Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa, " PLoS Pathogens, vol. 6, no. 5, Article ID e1000902, 2010.
40. S. C. Leahy, D. G. Higgins, G. F. Fitzgerald, and D. van Sinderen, "Getting better with bifidobacteria, " Journal of Applied Microbiology, vol. 98, no. 6, pp. 1303-1315, 2005.
41. C. Picard, J. Fioramonti, A. Francois, T. Robinson, F. Neant, and C. Matuchansky, "Reviewarticle: bifidobacteria as probiotic agents-physiological effects and clinical benefits, " Alimentary Pharmacology and Therapeutics, vol. 22, no. 6, pp. 495-512, 2005.
42. S. G. Jeon, H. Kayama, Y. Ueda et al., "Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon, " PLoS Pathogens, vol. 8, no. 5, Article ID e1002714, 2012.
43. H. Kayama, Y. Ueda, Y. Sawa et al., "IntestinalCX 3C chemokine receptor 1 high (CX 3CR1 high) myeloid cells prevent T-celldependent colitis, " Proceedings of the National Academy of Sciences of theUnited States of America, vol. 109, no. 13, pp. 5010-5015, 2012.
44. A. L. Hart, K. Lammers, P. Brigidi et al., "Modulation of human dendritic cell phenotype and function by probiotic bacteria, " Gut, vol. 53, no. 11, pp. 1602-1609, 2004.
45. P. Konieczna, D. Groeger, M. Ziegler et al., "Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells, " Gut, vol. 61, no. 3, pp. 354-366, 2012.
46. A. Lyons, D. OMahony, F. OBrien et al., "Bacterial strainspecific induction of Foxp3+ T regulatory cells is protective in murine allergy models, " Clinical and Experimental Allergy, vol. 40, no. 5, pp. 811-819, 2010.
47. P. López, I. González-Rodríguez, M. Gueimonde, A. Margolles, and A. Suárez, "Immune response to Bifidobacterium bifidum strains support Treg/Th17 plasticity, " PLoS ONE, vol. 6, no. 9, Article ID e24776, 2011.
48. S. Fanning, L. J. Hall, M. Cronin et al., "Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 6, pp. 2108-2113, 2012.
49. C. Di Giacinto, M. Marinaro, M. Sanchez, W. Strober, and M. Boirivant, "Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-β- bearing regulatory cells, " Journal of Immunology, vol. 174, no. 6, pp. 3237-3246, 2005.
50. P. Veiga, C. A. Gallini, C. Beal et al., "Bifidobacterium animalis subsp. Lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 42, pp. 18132-18137, 2010.
51. C. U. Riedel, F. Foata, D. Philippe, O. Adolfsson, B. J. Eikmanns, and S. Blum, "Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-κB activation, " World Journal of Gastroenterology, vol. 12, no. 23, pp. 3729-3735, 2006.
52. K. M. Lammers, U. Helwig, E. Swennen et al., "Effect of probiotic strains on interleukin 8 production by HT29/19A cells, " The American Journal of Gastroenterology, vol. 97, no. 5, pp. 1182-1186, 2002.
53. S. W. Kim, H. M. Kim, K. M. Yang et al., "Bifidobacteriumlactis inhibits NF-κB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice, " Inflammatory Bowel Diseases, vol. 16, no. 9, pp. 1514-1525, 2010.
54. S. Ménard, C. Cand alh, J. C. Bambou, K. Terpend, N. Cerf-Bensussan, and M. Heyman, "Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport, " Gut, vol. 53, no. 6, pp. 821-828, 2004.
55. E. Heuvelin, C. Lebreton, C. Grangette, B. Pot, N. Cerf- Bensussan, and M. Heyman, "Mechanisms involved in alleviation of intestinal inflammation by bifidobacterium breve soluble factors, " PLoS ONE, vol. 4, no. 4, Article ID e5184, 2009.
56. J. Preising, D. Philippe, M. Gleinser et al., "Selection of bifidobacteria based on adhesion and anti-inflammatory capacity in vitro for amelioration of murine colitis, " Applied and Environmental Microbiology, vol. 76, no. 9, pp. 3048-3051, 2010.
57. D. Philippe, E. Heupel, S. Blum-Sperisen, and C. U. Riedel, "Treatment with Bifidobacterium bifidum 17 partially protects mice from Th1-driven inflammation in a chemically induced model of colitis, " International Journal of Food Microbiology, vol. 149, no. 1, pp. 45-49, 2011.
58. J. McCarthy, L. OMahony, L. OCallaghan et al., "Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance, " Gut, vol. 52, no. 7, pp. 975-980, 2003.
59. J. B. Ewaschuk, H. Diaz, L. Meddings et al., "Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function, " The American Journal of Physiology- Gastrointestinal and Liver Physiology, vol. 295, no. 5, pp. G1025-G1034, 2008.
60. H.-K. Kwon, C.-G. Lee, J.-S. So et al., "Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 5, pp. 2159-2164, 2010.
61. T. Asahara, K. Nomoto, K. Shimizu, M. Watanuki, and R. Tanaka, "Increased resistance of mice to salmonella enterica serovar typhimurium infection by synbiotic administration of bifidobacteria and transgalactosylated oligosaccharides, " Journal of Applied Microbiology, vol. 91, no. 6, pp. 985-996, 2001.
62. T. Asahara, K. Shimizu, K. Nomoto, T. Hamabata, A. Ozawa, and Y. Takeda, "Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7, " Infection and Immunity, vol. 72, no. 4, pp. 2240-2247, 2004.
63. S. Fukuda, H. Toh, K. Hase et al., "Bifidobacteria can protect from enteropathogenic infection through production of acetate, " Nature, vol. 469, no. 7331, pp. 543-547, 2011.
64. J. S. Frick, K. Fink, F. Kahl et al., "Identification of commensal bacterial strains that modulate Yersinia enterocolitica and dextran sodium sulfate-induced inflammatory responses: implications for the development of probiotics, " Infection and Immunity, vol. 75, no. 7, pp. 3490-3497, 2007.
65. J. W. Collins, A. R. Akin, A. Kosta et al., "Pre-treatment with Bifidobacterium breve UCC2003 modulates Citrobacter rodentiuminduced colonic inflammation and organ specificity, " Microbiology, vol. 158, no. 11, pp. 2826-2834, 2012.
66. M. A. Schell, M. Karmirantzou, B. Snel et al., "The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract, " Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 22, pp. 14422-14427, 2002.
67. M. Ventura, S. OFlaherty, M. J. Claesson et al., "Genomescale analyses of health-promoting bacteria: probiogenomics, " Nature Reviews Microbiology, vol. 7, no. 1, pp. 61-71, 2009.
68. A. F. Hofmann, "The enterohepatic circulation of bile acids in mammals: form and functions, " Frontiers in Bioscience, vol. 14, no. 7, pp. 2584-2598, 2009.
69. P. B. Hylemon, H. Zhou, W. M. Pandak, S. Ren, G. Gil, and P. Dent, "Bile acids as regulatory molecules, " Journal of Lipid Research, vol. 50, no. 8, pp. 1509-1520, 2009.
70. M. Begley, C. G. M. Gahan, and C. Hill, "The interaction between bacteria and bile, " FEMS Microbiology Reviews, vol. 29, no. 4, pp. 625-651, 2005.
71. M. Begley, C. Hill, and C. G. M. Gahan, "Bile salt hydrolase activity in probiotics, " Applied and Environmental Microbiology, vol. 72, no. 3, pp. 1729-1738, 2006.
72. L. Ruiz, M. O'Connell-Motherway, A. Zomer, C. G. de los Reyes-Gavilán, A. Margolles, and D. van Sinderen, "A bileinduciblemembrane protein mediates bifidobacterial bile resistance, " Microbial Biotechnology, vol. 5, no. 4, pp. 523-535, 2012.
73. L. Ruiz, A. Zomer, M. O'Connell-Motherway, D. van Sinderen, and A. Margolles, "Discovering novel bile protection systems in Bifidobacterium breve UCC2003 through functional genomics, " Applied and Environmental Microbiology, vol. 78, no. 4, pp. 1123-1131, 2012.
74. M. Gueimonde, C. Garrigues, D. van Sinderen, C. G. de los Reyes-Gavilán, and A. Margolles, "Bile-inducible efflux transporter fromBifidobacterium longumNCC2705, conferring bile resistance, " Applied and Environmental Microbiology, vol. 75, no. 10, pp. 3153-3160, 2009.
75. G.-B. Kim and B. H. Lee, "Genetic analysis of a bile salt hydrolase in Bifidobacterium animalis subsp. lactis KL612, " Journal of Applied Microbiology, vol. 105, no. 3, pp. 778-790, 2008.
76. P. Jarocki, "Molecular characterization of bile salt hydrolase from bifidobacterium animalis subsp. Lactis Bi30, " Journal of Microbiology and Biotechnology, vol. 21, no. 8, pp. 838-845, 2011.
77. J.-P. Grill, F. Schneider, J. Crociani, and J. Ballongue, "Purification and characterization of conjugated bile salt hydrolase from Bifidobacterium longum BB536, " Applied and Environmental Microbiology, vol. 61, no. 7, pp. 2577-2582, 1995.
78. G.-B. Kim, C. M. Miyamoto, E. A. Meighen, and B. H. Lee, "Cloning and characterization of the bile salt hydrolase genes (bsh) fromBifidobacteriumbifidum strains, " Applied and EnvironmentalMicrobiology, vol. 70, no. 9, pp. 5603-5612, 2004.
79. G.-B. Kim, S.-H. Yi, and B. H. Lee, "Purification and characterization of three different types of bile salt hydrolases from Bifidobacterium strains, " Journal of Dairy Science, vol. 87, no. 2, pp. 258-266, 2004.
80. G.-B. Kim, M. Brochet, and B. H. Lee, "Cloning and characterization of a bile salt hydrolase (bsh) from Bifidobacterium adolescentis, " Biotechnology Letters, vol. 27, no. 12, pp. 817-822, 2005.
81. H. Tanaka, H. Hashiba, J. Kok, and I. Mierau, "Bile salt hydrolase of Bifidobacterium longum: biochemical and genetic characterization, " Applied and Environmental Microbiology, vol. 66, no. 6, pp. 2502-2512, 2000.
82. C. G. M. Gahan and C. Hill, "Gastrointestinal phase of Listeria monocytogenes infection, " Journal of Applied Microbiology, vol. 98, no. 6, pp. 1345-1353, 2005.
83. B. Sánchez, C. G. De Los Reyes-Gavilán, and A. Margolles, "The F1F0-ATPase of Bifidobacterium animalis is involved in bile tolerance, " Environmental Microbiology, vol. 8, no. 10, pp. 1825-1833, 2006.
84. D. Watson, R. D. Sleator, C. Hill, and C. G. M. Gahan, "Enhancing bile tolerance improves survival and persistence of Bifidobacterium and Lactococcus in the murine gastrointestinal tract, " BMC Microbiology, vol. 8, article 176, 2008.
85. M. Ventura, F. Turroni, M. O. Motherway, J. MacSharry, and D. van Sinderen, "Host-microbe interactions that facilitate gut colonization by commensal bifidobacteria, " Trends in Microbiology, vol. 20, no. 10, pp. 467-476, 2012.
86. D. Zhurina, A. Dudnik, M. S. Waidmann et al., "High-quality draft genome sequence of bifidobacteriumlongum E18, isolated from a healthy adult, " Genome Announcements, vol. 1, no. 6, 2013.
87. D. Zhurina, A. Zomer, M. Gleinser et al., "Complete genome sequence of Bifidobacterium bifidum S17, " Journal of Bacteriology, vol. 193, no. 1, pp. 301-302, 2011.
88. F. Bottacini, M. O'Connell Motherway, J. Kuczynski et al., "Comparative genomics of the Bifidobacterium breve taxon, " BMC Genomics, vol. 15, article 170, 2014.
89. D. A. Sela, J. Chapman, A. Adeuya et al., "The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 48, pp. 18964-18969, 2008.
90. D. A. Sela and D. A. Mills, "Nursing our microbiota: molecular linkages between bifidobacteria and milk oligosaccharides, " Trends in Microbiology, vol. 18, no. 7, pp. 298-307, 2010.
91. A. Marcobal and J. L. Sonnenburg, "Human milk oligosaccharide consumption by intestinal microbiota, " Clinical Microbiology and Infection, vol. 18, supplement 4, pp. 12-15, 2012.
92. F. Turroni, F. Bottacini, E. Foroni et al., "Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 45, pp. 19514-19519, 2010.
93. E. Holmes, J. Kinross, G. R. Gibson et al., "Therapeutic modulation of microbiota-host metabolic interactions, " Science Translational Medicine, vol. 4, no. 137, Article ID 137rv6, 2012.
94. R. G. LoCascio, P. Desai, D. A. Sela, B. Weimer, and D. A. Mills, "Broad conservation of milk utilization genes in Bifidobacterium longum subsp. infantis as revealed by comparative genomic hybridization, " Applied and Environmental Microbiology, vol. 76, no. 22, pp. 7373-7381, 2010.
95. D. A. Sela, D. Garrido, L. Lerno et al., "Bifidobacteriumlongum subsp. infantis ATCC 15697 α-fucosidases are active on fucosylated human milk oligosaccharides, " Applied and Environmental Microbiology, vol. 78, no. 3, pp. 795-803, 2012.
96. D. Garrido, C. Nwosu, S. Ruiz-Moyano et al., "Endo-β-Nacetylglucosaminidases frominfant gut-associated bifidobacteria release complexN-glycans fromhumanmilk glycoproteins, " Molecular and Cellular Proteomics, vol. 11, no. 9, pp. 775-785, 2012.
97. E. Yoshida, H. Sakurama, M. Kiyohara et al., "Bifidobacterium longum subsp. infantis uses two different β-galactosidases for selectively degrading type-1 and type-2 human milk oligosaccharides, " Glycobiology, vol. 22, no. 3, pp. 361-368, 2012.
98. M. E. V. Johansson, H. Sjövall, and G. C. Hansson, "The gastrointestinal mucus system in health and disease, " Nature Reviews Gastroenterology & Hepatology, vol. 10, pp. 352-561, 2013.
99. J. M. Laparra and Y. Sanz, "Comparison of in vitro models to study bacterial adhesion to the intestinal epithelium, " Letters in Applied Microbiology, vol. 49, no. 6, pp. 695-701, 2009.
100. E. Tuomola, R. Crittenden, M. Playne, E. Isolauri, and S. Salminen, "Quality assurance criteria for probiotic bacteria, " The American Journal of Clinical Nutrition, vol. 73, no. 2, pp. 393S-398S, 2001.
101. S. Lebeer, J. Vanderleyden, and S. C. J. de Keersmaecker, "Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens, " Nature Reviews Microbiology, vol. 8, no. 3, pp. 171-184, 2010.
102. M.-F. Bernet, D. Brassart, J.-R. Neeser, and A. L. Servin, "Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions, " Applied and Environmental Microbiology, vol. 59, no. 12, pp. 4121-4128, 1993.
103. M. Candela, S. Bergmann, M. Vici et al., "Binding of human plasminogen to Bifidobacterium, " Journal of Bacteriology, vol. 189, no. 16, pp. 5929-5936, 2007.
104. M. Candela, E. Biagi, M. Centanni et al., "Bifidobacterial enolase, a cell surface receptor for human plasminogen involved in the interaction with the host, " Microbiology, vol. 155, no. 10, pp. 3294-3303, 2009.
105. M. Candela, M. Centanni, J. Fiori et al., "DnaK from Bifidobacterium animalis subsp. lactis is a surface-exposed human plasminogen receptor upregulated in response to bile salts, " Microbiology, vol. 156, no. 6, pp. 1609-1618, 2010.
106. J. Crociani, J.-P. Grill, M. Huppert, and J. Ballongue, "Adhesion of different bifidobacteria strains to human enterocyte-like Caco-2 cells and comparison with in vivo study, " Letters in Applied Microbiology, vol. 21, no. 3, pp. 146-148, 1995.
107. B. DelRe, B. Sgorbati, M. Miglioli, and D. Palenzona, "Adhesion, autoaggregation and hydrophobicity of 13 strains of Bifidobacterium longum, " Letters in Applied Microbiology, vol. 31, no. 6, pp. 438-442, 2000.
108. P. K. Gopal, J. Prasad, J. Smart, and H. S. Gill, "Invitroadherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactisDR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli, " International Journal of Food Microbiology, vol. 67, no. 3, pp. 207-216, 2001.
109. S. Guglielmetti, I. Tamagnini, D. Mora et al., "Implication of an outer surface lipoprotein in adhesion of Bifidobacterium bifidum to Caco-2 cells, " Applied and Environmental Microbiology, vol. 74, no. 15, pp. 4695-4702, 2008.
110. S. Guglielmetti, I. Tamagnini, M. Minuzzo et al., "Study of the adhesion of Bifidobacterium bifidum MIMBb75 to human intestinal cell lines, " Current Microbiology, vol. 59, no. 2, pp. 167-172, 2009.
111. C. U. Riedel, F. Foata, D. R. Goldstein, S. Blum, and B. J. Eikmanns, "Interaction of bifidobacteria with Caco-2 cellsadhesion and impact on expression profiles, " International Journal of Food Microbiology, vol. 110, no. 1, pp. 62-68, 2006.
112. M. Gleinser, V. Grimm, D. Zhurina, J. Yuan, and C. U. Riedel, "Improved adhesive properties of recombinant bifidobacteria expressing the Bifidobacterium bifidum-specific lipoprotein BopA, "Microbial Cell Factories, vol. 11, article 80, 2012.
113. W.-H. Pan, P.-L. Li, and Z. Liu, "Thecorrelation between surface hydrophobicity and adherence of Bifidobacterium strains from centenarians faeces, " Anaerobe, vol. 12, no. 3, pp. 148-152, 2006.
114. M. Juntunen, P. V. Kirjavainen, A. C. Ouwehand , S. J. Salminen, and E. Isolauri, "Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection, " Clinical and Diagnostic Laboratory Immunology, vol. 8, no. 2, pp. 293-296, 2001.
115. P. V. Kirjavainen, A. C. Ouwehand , E. Isolauri, and S. J. Salminen, "The ability of probiotic bacteria to bind to human intestinalmucus, " FEMS Microbiology Letters, vol. 167, no. 2, pp. 185-189, 1998.
116. I. González-Rodríguez, B. Sánchez, L. Ruiz et al., "Role of extracellular transaldolase from Bifidobacterium bifidum in mucin adhesion and aggregation, " Applied and Environmental Microbiology, vol. 78, no. 11, pp. 3992-3998, 2012.
117. X. Wei, X. Yan, X. Chen et al., "Proteomic analysis of the interaction of Bifidobacterium longum NCC2705 with the intestine cells Caco-2 and identification of plasminogen receptors, " Journal of Proteomics, vol. 108, pp. 89-98, 2014.
118. B. Henderson and A. Martin, "Bacterial moonlighting proteins and bacterial virulence, " Current Topics in Microbiology and Immunology, vol. 358, pp. 155-213, 2013.
119. V. Kainulainen, J. Reunanen, K. Hiippala et al., "BopA has no major role in the adhesion of Bifidobacterium bifidum to intestinal epithelial cells, extracellular matrix proteins and mucus, " Applied and Environmental Microbiology, 2013.
120. C. Westermann, D. S. Zhurina, A. Baur, W. Shang, J. Yuan, and C. U. Riedel, "Exploring the genome sequence of Bifidobacterium bifidum S17 for potential players in host-microbe interactions, " Symbiosis, vol. 58, no. 1-3, pp. 191-200, 2012.
121. F. Turroni, F. Serafini, E. Foroni et al., "Role of sortasedependent pili of Bifidobacterium bifidum PRL2010 in modulating bacterium-host interactions, " Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 27, pp. 11151-11156, 2013.
122. M. O. Motherway, A. Zomer, S. C. Leahy et al., "Functional genome analysis of Bifidobacterium breve UCC2003 reveals type IVb tight adherence (Tad) pili as an essential and conserved host-colonization factor, " Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 27, pp. 11217-11222, 2011.
123. E. Foroni, F. Serafini, D. Amidani et al., "Genetic analysis and morphological identification of pilus-like structures in members of the genus Bifidobacterium, "Microbial Cell Factories, vol. 10, supplement 1, article S16, 2011.
124. C. Hidalgo-Cantabrana, B. Sánchez, C. Milani, M. Ventura, A. Margolles, and P. Ruas-Madiedo, "Genomic overview and biological functions of exopolysaccharide biosynthesis in Bifidobacteriumspp, " Appliedand EnvironmentalMicrobiology, vol. 80, pp. 9-18, 2014.
125. C. Hidalgo-Cantabrana, B. Sánchez, D. Moine et al., "Insights into the ropy phenotype of the exopolysaccharide-producing strain Bifidobacteriumanimalis subsp. lactis A1DOXR, " Applied and Environmental Microbiology, vol. 79, no. 12, pp. 3870-3874, 2013.
126. C. Hidalgo-Cantabrana, M. Nikolic, P. López et al., "Exopolysaccharide-producing Bifidobacterium animalis subsp. lactis strains and their polymers elicit different responses on immune cells from blood and gut associated lymphoid tissue, " Anaerobe, vol. 26, pp. 24-30, 2014.
127. M. Matsumoto, H. Ohishi, and Y. Benno, "H+-ATPase activity in Bifidobacterium with special reference to acid tolerance, " International Journal of Food Microbiology, vol. 93, no. 1, pp. 109-113, 2004.
128. M. Ventura, C. Canchaya, D. van Sinderen, G. F. Fitzgerald, and R. Zink, "Bifidobacterium lactis DSM 10140: identificafion of the atp (atpBEFHAGDC) operon and analysis of its genetic structure, characteristics, and phylogeny, " Applied and Environmental Microbiology, vol. 70, no. 5, pp. 3110-3121, 2004.
129. B. Sánchez, M.-C. Champomier-Vergès, M. D. C. Collado et al., "Low-pH adaptation and the acid tolerance response of Bifidobacterium longum biotype longum, " Applied and Environmental Microbiology, vol. 73, no. 20, pp. 6450-6459, 2007.
130. J. Yuan, B. Wang, Z. Sun et al., "Analysis of host-inducing proteome changes in Bifidobacterium longum NCC2705 grown in vivo, " Journal of Proteome Research, vol. 7, no. 1, pp. 375-385, 2008.
131. N. Parveen and K. A. Cornell, "Methylthioadenosine/Sadenosylhomocysteine nucleosidase, a critical enzyme for bacterial metabolism, "Molecular Microbiology, vol. 79, no. 1, pp. 7-20, 2011.
132. A. Vendeville, K. Winzer, K. Heurlier, C. M. Tang, and K. R. Hardie, "Making sense of metabolism: autoinducer-2, LuxS and pathogenic bacteria, " Nature Reviews Microbiology, vol. 3, no. 5, pp. 383-396, 2005.
133. C. S. Pereira, J. A. Thompson, and K. B. Xavier, "AI-2-mediated signalling in bacteria, " FEMS Microbiology Reviews, vol. 37, no. 2, pp. 156-181, 2013.
134. Z. Sun, X. He, V. F. Brancaccio, J. Yuan, and C. U. Riedel, "Bifidobacteria exhibit luxS-dependent autoinducer 2 activity and biofilm formation, " PLoS ONE, vol. 9, Article ID e88260, 2014.
135. S. E. A. Christiaen, M. O'Connell Motherway, F. Bottacini et al., "Autoinducer-2 plays a crucial role in gut colonization and probiotic functionality of Bifidobacterium breve UCC2003, " PLoS One, vol. 9, Article ID e98111, 2014.